نتایج جستجو برای: nras

تعداد نتایج: 2055  

Journal: :Cancer discovery 2014
Christin E Burd Wenjin Liu Minh V Huynh Meriam A Waqas James E Gillahan Kelly S Clark Kailing Fu Brit L Martin William R Jeck George P Souroullas David B Darr Daniel C Zedek Michael J Miley Bruce C Baguley Sharon L Campbell Norman E Sharpless

UNLABELLED NRAS mutation at codons 12, 13, or 61 is associated with transformation; yet, in melanoma, such alterations are nearly exclusive to codon 61. Here, we compared the melanoma susceptibility of an NrasQ61R knock-in allele to similarly designed KrasG12D and NrasG12D alleles. With concomitant p16INK4a inactivation, KrasG12D or NrasQ61R expression efficiently promoted melanoma in vivo, whe...

2016
Li-Ko Yeh Jie-Chun Luo Min-Chun Chen Chih-Hung Wu Jianzhang Chen I-Chun Cheng Cheng-Che Hsu Wei-Cheng Tian

A photoactivated gas detector operated at room temperature was microfabricated using a simple hydrothermal method. We report that the photoactivated gas detector can detect toluene using a UV illumination of 2 μW/cm². By ultraviolet (UV) illumination, gas detectors sense toluene at room temperature without heating. A significant enhancement of detector sensitivity is achieved because of the hig...

2013
Philipp Tschandl Anna Sophie Berghoff Matthias Preusser Sebastian Burgstaller-Muehlbacher Hubert Pehamberger Ichiro Okamoto Harald Kittler

According to the prevailing multistep model of melanoma development, oncogenic BRAF or NRAS mutations are crucial initial events in melanoma development. It is not known whether melanocytic nevi that are found in association with a melanoma are more likely to carry BRAF or NRAS mutations than uninvolved nevi. By laser microdissection we were able to selectively dissect and genotype cells either...

2016
Natália Duarte Linhares Maíra Cristina Menezes Freire Raony Guimarães Corrêa do Carmo Lisboa Cardenas Heloisa Barbosa Pena Katherine Lachlan Bruno Dallapiccola Carlos Bacino Bruno Delobel Paul James Ann-Charlotte Thuresson Göran Annerén Sérgio D. J. Pena

Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Victoria J Mar Stephen Q Wong Jason Li Richard A Scolyer Catriona McLean Anthony T Papenfuss Richard W Tothill Hojabr Kakavand Graham J Mann John F Thompson Andreas Behren Jonathan S Cebon Rory Wolfe John W Kelly Alexander Dobrovic Grant A McArthur

PURPOSE The mutation load in melanoma is generally high compared with other tumor types due to extensive UV damage. Translation of exome sequencing data into clinically relevant information is therefore challenging. This study sought to characterize mutations identified in primary cutaneous melanomas and correlate these with clinicopathologic features. EXPERIMENTAL DESIGN DNA was extracted fr...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Katarina Omholt Eva Grafström Lena Kanter-Lewensohn Johan Hansson Boel K Ragnarsson-Olding

PURPOSE A significant proportion of mucosal melanomas contain alterations in KIT. The aim of this study was to characterize the pattern of KIT, NRAS, and BRAF mutations in mucosal melanomas at specific sites and to assess activation of the KIT downstream RAF/MEK/extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/AKT pathways in mucosal melanoma specimens. EXPERIM...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Melissa A Wilson Fengmin Zhao Richard Letrero Kurt D'Andrea David L Rimm John M Kirkwood Harriet M Kluger Sandra J Lee Lynn M Schuchter Keith T Flaherty Katherine L Nathanson

PURPOSE Sorafenib is an inhibitor of VEGF receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and RAF kinases, amongst others. We assessed the association of somatic mutations with clinicopathologic features and clinical outcomes in patients with metastatic melanoma treated on E2603, comparing treatment with carboplatin, paclitaxel ± sorafenib (CP vs. CPS) EXPERIMENTAL DESIGN P...

Journal: :Dermato 2022

The high metastasis and mortality rates of melanoma in the era chemotherapy have decreased significantly over last 10 years. success is owed largely to introduction targeted therapy oncogenes immunotherapies, such as checkpoint inhibitors. aim present retrospective, monocentric study investigate impact or immunotherapy 550 patients with metastatic between years 2010 2019, looking at overall sur...

2018
Caglayan Geredeli Nurgul Yasar

BACKGROUND The aim of this study was to investigate the efficacy and safety of first-line panitumumab plus folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in patients with wild-type KRAS and wild-type NRAS metastatic colorectal cancer (mCRC). METHODS Patients with wild-type KRAS and wild-type NRAS mCRC presenting to the medical oncology department of the Okmeydani Training and Research ...

2015
Alan E. Siroy Genevieve M. Boland Denái R. Milton Jason Roszik Silva Frankian Jared Malke Lauren Haydu Victor G. Prieto Michael Tetzlaff Doina Ivan Wei-Lien Wang Carlos Torres-Cabala Jonathan Curry Sinchita Roy-Chowdhuri Russell Broaddus Asif Rashid John Stewart Jeffrey E. Gershenwald Rodabe N. Amaria Sapna P. Patel Nicholas E. Papadopoulos Agop Bedikian Wen-Jen Hwu Patrick Hwu Adi Diab Scott E. Woodman Kenneth D. Aldape Rajyalakshmi Luthra Keyur P. Patel Kenna R. Shaw Gordon B. Mills John Mendelsohn Funda Meric-Bernstam Kevin B. Kim Mark J. Routbort Alexander J. Lazar Michael A. Davies

The management of melanoma has evolved owing to improved understanding of its molecular drivers. To augment the current understanding of the prevalence, patterns, and associations of mutations in this disease, the results of clinical testing of 699 advanced melanoma patients using a pan-cancer next-generation sequencing (NGS) panel of hotspot regions in 46 genes were reviewed. Mutations were id...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید